Prof Derek Hausenloy
Meet Prof Derek Hausenloy, a leading cardiologist researching new ways to protect the heart from injury and failure, from lab studies to large clinical trials.
Prof Derek Hausenloy
Prof Derek Hausenloy is Professor in the Cardiovascular & Metabolic Disorders Signature Programme, Duke-National University of Singapore Medical School, and Research Director and Senior Consultant Cardiologist at the National Heart Research Institute Singapore, National Heart Centre Singapore.
He is also Professor in the Institute of Cardiovascular Sciences, University College London, UK. He is a National Medical Research Council STaR Investigator Award who conducts basic, translational and clinical research in the areas of ischaemic heart disease, heart failure, cardioprotection, and cardiac MRI.
His main research focus is on discovering novel therapies for protecting the heart against acute ischaemia/reperfusion injury and heart failure. His research ranges from cellular and animal disease models of cardiovascular disease to proof-of-concept clinical studies in acute myocardial infarction, heart failure and cardiac bypass surgery patients, and finally to large multi-centre randomised clinical trials focused on clinical outcomes. He also uses human iPSC-derived cardiomyocytes to model cardiomyopathies to elucidate underlying mechanisms and identify novel therapeutic targets and has interests in cardiac MRI, nanotechnology for drug delivery, and discovering new treatment targets for peripheral arterial disease.
He has been a PI on over 40 research grants, has authored over 350 papers (H-index 101), and was named Highly Cited Researcher by Clarivate Analytics (awarded to the top 1% of researchers worldwide) in 2018, 2020, 2021, and 2022.